603392 万泰生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.9859.96556.35357.59232.924
总资产报酬率 ROA (%)0.8047.81240.69338.32323.886
投入资产回报率 ROIC (%)0.9549.62653.87553.90831.843

边际利润分析
销售毛利率 (%)73.05385.62689.53685.78081.219
营业利润率 (%)16.99925.43150.03140.49332.928
息税前利润/营业总收入 (%)14.20023.59849.36140.50832.954
净利润/营业总收入 (%)17.24722.61943.48036.15828.961

收益指标分析
经营活动净收益/利润总额(%)63.926117.12997.395100.950100.280
价值变动净收益/利润总额(%)36.2288.8670.8260.4841.825
营业外收支净额/利润总额(%)-1.816-0.578-0.239-0.185-1.406

偿债能力分析
流动比率 (X)4.1983.8583.4951.9642.386
速动比率 (X)3.8393.5193.2451.7131.903
资产负债率 (%)16.40518.01722.58035.24726.352
带息债务/全部投入资本 (%)2.5423.2152.6285.1440.910
股东权益/带息债务 (%)3,821.0432,999.3583,682.8421,798.49210,500.828
股东权益/负债合计 (%)502.239448.572336.767179.842276.584
利息保障倍数 (X)-5.690-13.986-89.610448.35068.254

营运能力分析
应收账款周转天数 (天)349.873226.37099.70192.25672.086
存货周转天数 (天)390.461403.260224.891218.631259.113